Healthcare -
Biotechnology - NASDAQ - US
$ 5.33
-2.2 %
$ 166 M
Market Cap
-2.0
P/E
ACRV - PRE-TAX INCOME
Pre-tax Income ACRV - Acrivon Therapeutics, Inc. Common Stock
-60.4 M
LAST VALUE
-92.82%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR